Linden Advisors’s GeneDx Holdings Warrant WGSWW Stock Holding History

Linden Advisors’s Portfolio WGSWW Stock Details WGSWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-678,243	Closed	-$661K	–	752
2021 Q4	$661K	Hold	678,243	–	–	﹤0.01%	524
2021 Q3	$1.45M	Hold	678,243	–	–	0.01%	404
2021 Q2	$3.1M	Hold	678,243	–	–	0.02%	413
2021 Q1	$3.41M	Sell	678,243 -21,790	-3%	-$121K	0.03%	378
2020 Q4	$1.97M	Buy	+700,033	New	+$1.76M	0.01%	324

Other funds holding WGSWW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

DCM

Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return

BCP

Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Islet Management New York $49.1M AUM 17.59% 1-Year Est. Return

Linden Advisors's WGSWW Position: Q1 2022 in Review

Linden Advisors sold out of GeneDx Holdings Warrant (WGSWW) in Q1 2022, closing a stake of 678,243 shares — an estimated $661K sold.

Linden Advisors first reported a position in WGSWW in Q4 2020 and held it in 5 quarters. The position peaked at $3.41M in Q1 2021. 27 funds tracked by Wall St. Rank hold WGSWW as of Q1 2022.

Linden Advisors reported no remaining GeneDx Holdings Warrant position as of Q1 2022 after selling out during the quarter.
Linden Advisors sold 678,243 GeneDx Holdings Warrant shares in Q1 2022, an estimated $661K.
Linden Advisors first reported a position in GeneDx Holdings Warrant in Q4 2020 and held it in 5 quarters.
Linden Advisors's GeneDx Holdings Warrant position peaked at $3.41M in Q1 2021.
27 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q1 2022.

Based on Linden Advisors's 13F filing for Q1 2022, filed 16 May 2022.